Inspire Medical Systems (INSP) Change in Accured Expenses (2017 - 2026)

Inspire Medical Systems has reported Change in Accured Expenses for 10 years, with the latest figure at -$12.3 million in Q1 2026.

• Quarterly Change in Accured Expenses rose 24.47% year-over-year to -$12.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.1 million (up 13.05% YoY) and the FY2025 annual result came in at $6.1 million, down 52.41% from the prior year.
• Change in Accured Expenses fell to -$12.3 million in Q1 2026 per INSP's latest filing, from $6.6 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $13.7 million in Q4 2024 and troughed at -$16.3 million in Q1 2025.
• A 5-year average of $1.5 million and a median of $4.5 million in 2022 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses tumbled 126.99% in 2022, then soared 105.35% in 2023.
• Over 5 years, Change in Accured Expenses stood at $4.9 million in 2022, then jumped by 105.35% to $10.1 million in 2023, then soared by 35.38% to $13.7 million in 2024, then plunged by 51.44% to $6.6 million in 2025, then plunged by 285.82% to -$12.3 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$12.3 million, $6.6 million, and $10.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.